Navigation Links
Schering-Plough Reports Top-Line Results of the IDEAL Study
Date:1/14/2008

roval commitment to the U.S. Food and Drug Administration (FDA). The comparison of the PEGINTRON and Pegasys combination therapy regimens was added to the study because no randomized, controlled head-to-head study of the two available peginterferon regimens had been conducted to date. Cross-study comparisons and retrospective analyses of previous data are difficult to interpret because of differences in study designs, patient populations and assay limits.

John McHutchison, M.D., and Mark Sulkowski, M.D., are the co-principal investigators of the IDEAL study. They also are co-chairmen of the IDEAL Publication Committee, which also includes three independent expert members not associated with the study to assure an unbiased evaluation of the data. The Publication Committee was responsible for the preparation of the prespecified data analysis plan for the statistical analysis conducted for the primary publication of the study results.

About Hepatitis C

Hepatitis C is a serious and potentially life-threatening disease. It is the most common blood-borne infection in America and the most common form of liver disease, affecting nearly 5 million people in the United States and some 170 million people worldwide. It is the leading cause of cirrhosis and liver cancer, and the number one reason for liver transplants in the United States.

About PEGINTRON

In the United States, PEGINTRON is indicated for use alone or with ribavirin for the treatment of chronic hepatitis C in patients with compensated liver disease who have not been previously treated with interferon alpha and who are at least 18 years of age.

Important Safety Information Regarding U.S. Labeling for PEGINTRON and REBETOL

Alpha interferons, including PEGINTRON and INTRON(R) A, may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory eval
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
2. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
3. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
4. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
5. Second Thoughts about Fluoride, Reports Scientific American
6. SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor
7. Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients
8. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
9. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
10. Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
11. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... MELBOURNE, Australia , Sept. 18, 2014 /PRNewswire/ ... the appointments of Dr. Ashraf Hanna , M.D., ... to its Board of Directors. Dr. Hanna is the ... Genentech and Chief Financial Officer for the Genentech Foundation, ... and Global Head of Business Development and Licensing for ...
(Date:9/18/2014)... , Sept. 18, 2014  Spring Bank ... therapeutics for the treatment of RNA viruses, today ... of Health (NIH) for animal testing of the ... pathogens, classified as "Special Pathogens," against which currently ... derived from Spring Bank,s proprietary Small ...
(Date:9/18/2014)... , Sept. 18, 2014   Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced the first presentation ... AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of Collagenase Optimizing ... study evaluated collagenase clostridium histolyticum (CCH) for the ... same hand. In addition, the study examined expanded ...
Breaking Medicine Technology:Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 6Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting 7
... , , ... Incorporated, (IDEV) an emerging leader in the development and marketing ... patient was enrolled in the Company,s FDA-approved multi-center clinical trial ... for the treatment of biliary and peripheral artery disease (PAD) ...
... RYE, N.Y., Aug. 24 Curemark Founder and CEO Dr. ... International Epigenomics, Sequencing 2009 Conference at Harvard Medical School on ... to address this cutting-edge conclave is particularly significant, since epigenetics ... occur without a change in the DNA sequence. Presenters at ...
Cached Medicine Technology:IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent 2Curemark CEO Presents at Epigenomics Conference 2
(Date:9/18/2014)... (PRWEB) September 18, 2014 Ben Quirk, ... Alex Ormond, Jr. Leadership Award by the Savannah Science ... healthcare and wellness throughout the nation and especially in ... this award,” said Ben. “The Savannah Science Seminar is ... years and multiple generations have gone through the program,” ...
(Date:9/18/2014)... for Fortune 500 companies can expect to pay higher ... survey of chief human resource officers about the impact ... known as PPACA or Obamacare) conducted by the Darla ... Carolina this past May/June. , Patrick Wright, a professor ... HR@Moore Survey of Chief HR Officers. The survey is ...
(Date:9/18/2014)... 2014 ChopChop founder Sally Sampson ... Yonah Kalikow, 10-year-old Massachusetts’s winner of the First Lady’s Healthy ... the classic Middle Eastern bean dip. Watch as Bill and ... can create their own healthy dips at home. The cooking ... annual Let’s Talk About Food Festival in Copley ...
(Date:9/18/2014)... A sold-out crowd of more than 300 ... United Way of Westchester and Putnam at ... Monday, Sept. 15. Proceeds from the event will ... Putnam, such as providing healthy foods to low-income families, ... behaviors like drug and alcohol usage. , Two dozen ...
(Date:9/18/2014)... broadly effective vaccines to prevent the spread of illnesses ... has been made along these lines, there are still ... from these devastating diseases. , So what are ... At Caltech, Nobel Laureate David Baltimore and his colleagues ... vaccines introduce substances such as antigens into the body ...
Breaking Medicine News(10 mins):Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Survey: Fortune 500 employees can expect to pay more for health insurance 2Health News:Survey: Fortune 500 employees can expect to pay more for health insurance 3Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 2Health News:Award-Winning Cooking Magazine for Kids Challenges Former White House Pastry Chef and 10-Year-Old Chef to Cook Up a Healthy Snack 3Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3Health News:A new way to prevent the spread of devastating diseases 2Health News:A new way to prevent the spread of devastating diseases 3Health News:A new way to prevent the spread of devastating diseases 4Health News:A new way to prevent the spread of devastating diseases 5
... , , LOS ANGELES, Dec. 23 The 15th annual ... multiple broadcasts, cable and satellite networks, as well as the ... other notables include Celine Dion, Garth Brooks, Reba McIntyre, Sandra ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091223/DC30052 ) , Former President George Herbert ...
... Marianjoy Rehabilitation Hospital,s Medical Director of Pediatric Rehabilitation, ... top doctors by Chicago Magazine . Dr. Keen ... Marianjoy, focusing much of her work with children who ... , Dr. Keen is board certified in four ...
... Calif., Dec. 23 Lakeside Medical Organization and CEO ... Chamber of Commerce for significant community outreach. , Judee ... Lakeside in recognition of "outstanding contributions to the community, ... quality care." , Lakeside Medical Organization is part of ...
... increased risk of the H1N1 flu in these two groups, ... women are hit hardest by the pandemic H1N1 flu, two ... Dec. 24 issue of the New England Journal of ... and postpartum women," said Ken August, a spokesman for the ...
... protection, experts say, , WEDNESDAY, Dec. 23 (HealthDay News) ... the holidays can have a dark side, with asymptomatic ... , "Kids get colonized by strep and pneumococcus, and ... sick from it, but the elderly are more susceptible ...
... EDINA, Minn., Dec. 23 As we try to get outside ... to use basic safety tips that help minimize injury. The Minnesota ... family injury free. , -- Everything you wanted to know about ... on the musculoskeletal system. If you must shovel, be careful and ...
Cached Medicine News:Health News:Top Stars Rally for Fighting Blindness, Sending Their Message out to 160 Million Homes on Multiple Cable Networks, December 25th, Preceded by President George Herbert Walker Bush Describing the Frank Capra Classic, 'It's A Wonderful Life' for the Bl 2Health News:Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by Glendale Chamber of Commerce 2Health News: Swine Flu Hits Pregnant Women, Kids Hardest 2Health News: Swine Flu Hits Pregnant Women, Kids Hardest 3Health News:Kids Can Pass Pneumonia Bug to Older Relatives During Holidays 2Health News:WINTER SAFETY: Does the Body Good 2
For use with catalog #0540....
Lupus Anticoagulant-Sensitive APTT Reagent.Cephalin with particulate activator (silica), freeze-dried....
Antigenic Total Protein S, ELISA Method...
Colorimetric Assay of Antithrombin III Activity by STA© Analyzers. Bovine thrombin ~12NIH units/mL, freeze-dried....
Medicine Products: